MedPath

Characterisation of the skeletal muscles of patients with facioscapulohumeral muscular dystrophy by quantitative 1H and X-nuclei MRI

Conditions
G71.0
Muscular dystrophy
Registration Number
DRKS00031901
Lead Sponsor
niversitätsklinikum Erlangen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Ambulant, at least for short distances.
- Willingness and ability to participate, sufficient knowledge of German to understand the declaration of consent, or if not possible, test subject information and support in the mother tongue or, if necessary, in English
- Probability that the subjects/patients can complete the study (defined by the ability to lie still for approximately 1 hour)

Exclusion Criteria

- General contraindications for MRI examinations
- Electrical implants such as cardiac pacemakers or perfusion pumps
- Pronounced claustrophobia
- Study participants with ferromagnetic or electrically conductive implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, heart valves with metal parts, metal splinters, tattoos near the eye, symmetrical tattoos on the extremities or steel implants must be discussed with the study physician; they may not be examined (relative contraindications for MRI).
- Prohibited concomitant medication: Strongly sedating medications are to be ruled out, since intensive monitoring of body functions during ongoing imaging cannot be guaranteed and the examination is dependent on the active participation of the subject.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fat fraction (FF) and total sodium concentration (TSC) in lower leg muscle.<br>1 and 12 months in patients<br>Once in healthy controls
Secondary Outcome Measures
NameTimeMethod
Water T2 and T1 (transverse and longitudinal relaxation times) and total potassium concentration (TPC) in lower leg muscles
© Copyright 2025. All Rights Reserved by MedPath